Dr Tania Sorrell has longstanding interests in prevention, diagnosis and treatment of Infectious Diseases, especially in immune-compromised hosts, and in the emergence of resistant microorganisms. Her research into the serious fungal infection, cryptococcosis, has provided new insights into host-microbial interactions and resulted in a new antifungal drug development program. She has developed new diagnostics for fungal diseases, led national studies of the epidemiology of invasive fungal infections and is/has been a member of international committees developing guidelines for antifungal therapy. She has served/serves on state and national advisory committees in Infectious Diseases, approval of therapeutic agents and both the Research and Human Ethics Committees of the National Health and Medical Research Council of Australia.